Mitochondrial folate transport by SLC25A32 is yet unstudied for its contribution to oncogenesis,
despite knowledge that the slc25a32 gene is amplified in human
cancers (including > 40 % of
breast cancers) and this amplification is associated with accelerated disease progression and
death.